Company profile
Glaxosmithkline Services Unlimited
Patient Welcome Page
Glaxosmithkline Services Unlimited is a UK company with status active founded in 1972 based in London.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Change Person Secretary Company With Change Date
OfficersCH03 | Transaction MzQzNjY4MTA0NmFkaXF6a2N4
Published 23 Sep 2024 06:42
Change Person Director Company With Change Date
OfficersCH01 | Transaction MzQzNjY4MTEwMWFkaXF6a2N4
Published 23 Sep 2024 06:36
Change Person Director Company With Change Date
OfficersCH01 | Transaction MzQzNjAyNjc4M2FkaXF6a2N4
Published 17 Sep 2024 06:29
Change To A Person With Significant Control
Persons-with-significant-controlPSC05 | Transaction MzQzNTI0NDMyNmFkaXF6a2N4
Published 02 Oct 2024 01:56
Change Registered Office Address Company With Date Old Address New Address
AddressAD01 | Transaction MzQzNTIyMjQxNmFkaXF6a2N4
Published 11 Sep 2024 02:01
Accounts With Accounts Type Full
Accounts PDF pendingAA | Transaction MzQzNDMxMjM2N2FkaXF6a2N4 | Paper/PDF filed
Published 06 Sep 2024 11:26
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzQzMjMzNzY3NmFkaXF6a2N4
Published 15 Aug 2024 10:12
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Optimising Energy Efficiency for Sustainable Medicines Manufacturing
1 Jan 2025 to 31 May 2025
This project introduces an innovative, large-scale approach to reducing energy consumption within the UK's medicines manufacturing sector, a sector that faces unique sustainability challenges due to its energy-intensive processes and stringent regulatory requirements. The project focuses on Productivity and Resource Efficiency, aiming to significantly low...
Accelerating paediatric formulation development through smart design and predictive science
1 Jul 2014 to 31 Mar 2018
This project is a collaboration between large UK pharmaceutical companies, academia and technology suppliers to generate a structured approach to designing age-appropriate medicines for children and technology for predicting their quality and performance. Paediatric medicine is currently a "hot-topic" within the pharmaceutical industry and there is a lot ...
Digital Design of Drug Products
1 Jun 2014 to 31 May 2016
This project brings together experts in drug development, product formulation, process design, systems modelling and manufacture to create a completely new approach to the design and manufacture of formulated drug products, which involves the integration of qualitative tools for process understanding with a range of in-silico models which describe and pre...
Development of an Innovative Modular System for Continuous Chemical Processing
1 Apr 2013 to 30 Sep 2016
The project, lead by Syrris, in collaboration with GSK, AMRI UK and the EPSRC Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation will develop an innovative modular system for continuous chemical processing. It will develop modules that can be used by any chemical industry to perform unit operations such as liquid-liquid, l...